{
    "CMPK2": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"CMPK2\",",
            "  \"brief_summary\": \"CMPK2 (Cytidine/UMP-Cytidine Monophosphate Kinase 2) is a gene that encodes an enzyme involved in the pyrimidine nucleotide salvage pathway. It is crucial for the synthesis of UTP and CTP, which are essential for RNA and DNA synthesis. CMPK2 is also known to be induced by type I interferon and plays a role in the innate immune response to viral infection.\",",
            "",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the assigned scores are not definitive and can vary based on emerging research and evidence. They are provided based on the information available at the time of the knowledge cutoff and are intended to represent a general estimation of evidence strength."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"CMPK2\",",
            "  \"brief_summary\": \"The gene CMPK2 (Cytidine/uridine monophosphate kinase 2) encodes an enzyme that is involved in the de novo synthesis of UTP and CTP, which are necessary for the synthesis of RNA and DNA. CMPK2 is also known to be induced by type I interferons and plays a role in the antiviral response by participating in the production of cellular nucleotides used for the synthesis of viral RNA and DNA.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "The scores provided are estimations based on current knowledge and available research. They reflect the strength of the association between the gene CMPK2 and the given statements. A score of 10 represents high evidence, while a score of 0 represents low evidence for the association. Please note that the actual evidence may evolve with ongoing research, and these scores should be interpreted within the context of the current scientific literature."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"CMPK2\",",
            "  \"brief_summary\": \"CMPK2 (Cytidine/Uridine Monophosphate Kinase 2) is a gene that encodes a protein involved in the de novo synthesis and salvage pathways of pyrimidine ribonucleotide triphosphates. CMPK2 is primarily known for its role in the cellular antiviral response and is induced by interferon. It is implicated in the metabolism of cytidine and uridine monophosphate, and it potentially plays a role in immune responses through its influence on pyrimidine nucleotide levels, which can affect RNA synthesis and the replication of RNA viruses.\",",
            "  \"statements_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 8,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 6,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that these scores are subjective estimates based on current scientific knowledge, and they should be interpreted within the context of ongoing research. The scores could change with new discoveries, and they should be corroborated with additional sources of information for any clinical or research purposes."
        ]
    },
    "IFI27": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IFI27\",",
            "  \"brief_summary\": \"The IFI27 gene, also known as Interferon Alpha Inducible Protein 27, encodes a protein that is highly upregulated in response to type I interferons. IFI27 is involved in the innate immune response and may play a role in apoptosis and cell proliferation. It has been studied in various contexts including viral infections, cancer, and as a potential biomarker for certain conditions.\"",
            "}",
            "",
            "{",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 3,",
            "  \"The gene is associated with type III interferon responses\": 2,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "}",
            "```",
            "",
            "These scores are provided based on the current knowledge and available literature. They reflect an estimate of the strength of evidence for each statement, with higher numbers indicating stronger evidence. The scoring may vary depending on new research findings."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IFI27\",",
            "  \"brief_summary\": \"The IFI27 gene, also known as Interferon Alpha Inducible Protein 27, encodes a protein that is involved in the innate immune response to viral infection. It is induced by type I interferons and plays a role in apoptosis, cell growth regulation, and immune system signaling.\",",
            "  \"statements\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided here are a subjective estimation based on general knowledge of the gene's functions and are not based on specific scientific evidence. The actual evidence for each statement can vary and should be referenced from specific scientific research."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"IFI27\",",
            "  \"brief_summary\": \"The IFI27 gene encodes a protein that is involved in the innate immune response to viral infection. It is induced by interferons, which are cytokines that mediate antiviral and immune responses. The IFI27 protein is known to be upregulated in response to type I interferons and plays a role in cellular apoptosis and the immune response to viral infection.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 3,",
            "    \"The gene is associated with type III interferon responses\": 2,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```"
        ]
    },
    "IFIT1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IFIT1\",",
            "  \"brief_summary\": \"The IFIT1 gene, also known as Interferon-Induced Protein With Tetratricopeptide Repeats 1, is involved in the innate immune response to viral infection. The protein encoded by this gene is induced by interferons and plays a role in antiviral defense mechanisms by binding to viral RNA and inhibiting viral replication. It is particularly associated with responses to type I interferons.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 5,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IFIT1\",",
            "  \"brief_summary\": \"IFIT1, also known as Interferon-Induced Protein with Tetratricopeptide Repeats 1, is a protein that in humans is encoded by the IFIT1 gene. This gene is stimulated by type I interferons and plays a critical role in the innate immune response against viral infections. IFIT1 can inhibit viral replication by binding to the viral RNA and preventing its translation. It also interacts with other proteins within the interferon-induced antiviral pathway to modulate immune responses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 5,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "    \"gene_name\": \"IFIT1\",",
            "    \"brief_summary\": \"The IFIT1 gene encodes for a protein known as Interferon-Induced Protein With Tetratricopeptide Repeats 1. It plays a critical role in the innate immune response to viral infection. IFIT1 is induced by interferon signaling and is involved in the inhibition of viral replication by binding to viral RNA. It is one of the interferon-stimulated genes that contribute to the antiviral state of cells.\",",
            "    \"evidence_scores\": {",
            "        \"The gene is associated with type I interferon responses\": 10,",
            "        \"The gene is associated with type II interferon responses\": 6,",
            "        \"The gene is associated with type III interferon responses\": 7,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "        \"The gene is a known drug target\": 1,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "    }",
            "}",
            "```"
        ]
    },
    "IFITM3": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"IFITM3\",",
            "  \"Brief_summary\": \"IFITM3, or Interferon Induced Transmembrane Protein 3, is a member of the interferon-inducible transmembrane protein family. This gene plays a significant role in the immune response to viral infections. It is involved in the inhibition of the replication of many viruses by interfering with the early stages of viral replication, and it enhances cellular resistance to viral infection. IFITM3 is particularly important in the context of influenza virus, as it has been shown to inhibit the virus's entry into cells.\",",
            "",
            "  \"The gene is associated with type I interferon responses\": 10,",
            "  \"The gene is associated with type II interferon responses\": 5,",
            "  \"The gene is associated with type III interferon responses\": 7,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"IFITM3\",",
            "  \"brief_summary\": \"Interferon induced transmembrane protein 3 (IFITM3) is a gene that encodes a protein involved in the cellular immune response to viral infection. It belongs to the interferon-induced transmembrane protein family which plays a critical role in inhibiting the replication of various respiratory viruses, including influenza virus and coronaviruses. IFITM3 is expressed in various tissues and is known to be upregulated in response to type I interferons. The protein encoded by IFITM3 is thought to interfere with the viral replication cycle by inhibiting virus-cell fusion and entry into host cells.\",",
            "  \"The gene is associated with type I interferon responses\": 10,",
            "  \"The gene is associated with type II interferon responses\": 5,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "}",
            "```",
            "",
            "Please note that the scores provided are estimates based on the current understanding of the gene as of my knowledge cutoff in early 2023. These scores reflect the level of evidence supporting each statement, with 0 indicating low evidence and 10 indicating high evidence. The scores for the association with type II and type III interferon responses are given a mid-range value due to the primary association of IFITM3 with type I interferon responses, although there may be some evidence for cross-talk or secondary association with other types of interferon responses. The scores may vary as new research emerges."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"IFITM3\",",
            "  \"Brief_summary\": \"Interferon Induced Transmembrane Protein 3 (IFITM3) is a gene that encodes a protein involved in the immune response to viral infections. It is a member of the interferon-inducible transmembrane protein family and is known to restrict the entry and replication of several enveloped viruses. The protein is also implicated in the modulation of cell proliferation, adhesion, and the immune system's response to viral infections through its role in interferon signaling pathways.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 6,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ]
    },
    "LAMP3": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"LAMP3\",",
            "  \"brief_summary\": \"LAMP3, also known as DC-LAMP or CD208, is a member of the Lysosomal Associated Membrane Protein (LAMP) family. LAMP3 is primarily expressed in dendritic cells and has a role in the immune response, including antigen presentation and lymphocyte activation. It is also involved in various cellular processes such as cell adhesion, signal transduction, and apoptosis.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a hypothetical assessment and should not be used as a definitive guide to the current state of knowledge regarding LAMP3. They are meant to illustrate how evidence may be scored based on available research, and the actual evidence may vary. The brief summary is a general description based on typical functions of the gene and should be corroborated with up-to-date scientific research for precise information."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "    \"gene_name\": \"LAMP3\",",
            "    \"Brief_summary\": \"LAMP3, or Lysosomal-associated membrane protein 3, is a protein that in humans is encoded by the LAMP3 gene. It is a member of the LAMP family of proteins which are involved in lysosome stability and function. LAMP3 is known to play a role in cell adhesion, chemoattraction for neutrophils, and is potentially implicated in tumor metastasis. It is also associated with the immune response, particularly in the context of dendritic cell maturation and antigen presentation.\",",
            "    \"scores\": {",
            "        \"The gene is associated with type I interferon responses\": 7,",
            "        \"The gene is associated with type II interferon responses\": 4,",
            "        \"The gene is associated with type III interferon responses\": 3,",
            "        \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "        \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "        \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "        \"The gene is a known drug target\": 2,",
            "        \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "    }",
            "}",
            "```",
            "",
            "Please note that the scores are a heuristic estimate based on current scientific understanding, which may evolve with ongoing research."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"LAMP3\",",
            "  \"brief_summary\": \"LAMP3, also known as DC-LAMP or CD208, is a member of the lysosomal-associated membrane protein (LAMP) family. It is primarily expressed in dendritic cells and is involved in the regulation of immune responses, antigen presentation, and lysosome stability. The protein encoded by LAMP3 is found in the lysosomal membrane and may play a role in the maturation and activation of dendritic cells, which are crucial for initiating adaptive immune responses.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 4,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores assigned to each statement are hypothetical and based on a general understanding of the gene's role in the immune system. These scores should not be considered as definitive evidence without further research and validation from scientific studies."
        ]
    },
    "OAS1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"OAS1\",",
            "  \"brief_summary\": \"OAS1 (2'-5'-oligoadenylate synthetase 1) is an enzyme that is induced by interferons, particularly type I interferons, and plays a critical role in the innate immune response against viral infections. Upon activation by viral double-stranded RNA, OAS1 catalyzes the synthesis of 2'-5'-oligoadenylates (2-5As), which in turn activate RNase L, leading to the degradation of viral RNA and inhibition of viral replication.\",",
            "  \"statement_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided here are a subjective estimate based on the current knowledge as of the last update and may not reflect the latest research. The scores should be independently verified with current scientific literature for accuracy."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"OAS1\",",
            "  \"Brief_summary\": \"OAS1 (2'-5'-Oligoadenylate Synthetase 1) is an enzyme that is induced by interferons and plays a role in the antiviral defense system of cells. It synthesizes 2'-5'-oligoadenylates (2-5As) which activate RNase L, leading to the degradation of viral RNA. OAS1 is part of the OAS family that detects viral double-stranded RNA (dsRNA) in infected cells.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 6,",
            "    \"The gene is associated with type III interferon responses\": 5,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"OAS1\",",
            "  \"brief_summary\": \"OAS1, or 2'-5'-oligoadenylate synthetase 1, is a gene that encodes an enzyme involved in the antiviral response of the immune system. The enzyme synthesized by the OAS1 gene is part of the innate immune response and is typically induced by type I interferons. Upon viral infection, OAS1 produces 2'-5'-oligoadenylates, which activate RNase L, leading to the degradation of viral and cellular RNA, thereby inhibiting viral replication.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ]
    },
    "OAS2": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"OAS2\",",
            "  \"Brief_summary\": \"OAS2 (2'-5'-Oligoadenylate Synthetase 2) is a gene that encodes for an enzyme involved in the antiviral defense mechanism of the host. This enzyme is activated by viral double-stranded RNA and plays a role in the innate immune response by catalyzing the synthesis of 2'-5'-oligoadenylates (2-5A). These molecules activate RNase L, which degrades viral and cellular RNA, thus inhibiting virus replication and spreading.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 6,",
            "  \"The gene is associated with type III interferon responses\": 5,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"OAS2\",",
            "  \"brief_summary\": \"OAS2 (2'-5'-Oligoadenylate Synthetase 2) is a gene that encodes for an enzyme involved in the antiviral response. This enzyme is activated by double-stranded RNA, a byproduct of viral infection, and catalyzes the synthesis of 2'-5'-oligoadenylates (2-5A). These molecules activate RNase L, which degrades viral and cellular RNA. OAS2 is one of the key components in the innate immune response against viral infections and is induced by interferons.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided above are not based on a specific quantitative analysis but are rather a qualitative estimation based on general knowledge of the gene's functions and its role in immunity up to my current knowledge cutoff in 2023. Actual evidence supporting these statements may vary, and it is advisable to consult the latest scientific research for more precise information."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"OAS2\",",
            "  \"brief_summary\": \"OAS2 (2'-5'-Oligoadenylate Synthetase 2) is a gene that codes for an enzyme involved in the antiviral response of cells. This enzyme synthesizes 2'-5'-oligoadenylates (2-5A) which activate RNase L, leading to the degradation of viral RNA and inhibition of viral replication. OAS2 is one of the genes induced by interferons, particularly type I interferons, as part of the innate immune response to viral infection.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 10,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 4,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "    \"The gene is a known drug target\": 2,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "  }",
            "}",
            "```"
        ]
    },
    "OASL": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"OASL\",",
            "  \"Brief_summary\": \"The OASL gene encodes an enzyme that is part of the OAS (2'-5'-oligoadenylate synthetase) family. This family of enzymes play a critical role in the cellular innate immune response by being activated by viral double-stranded RNA and then synthesizing 2'-5'-linked oligomers of adenosine (2-5A), which in turn activate RNase L that degrades viral and cellular RNA. OASL has been shown to enhance the antiviral effects of type I interferons and may also modulate other aspects of the innate immune response.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 5,",
            "  \"The gene is associated with type III interferon responses\": 4,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 3,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 2,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```"
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"OASL\",",
            "  \"Brief_summary\": \"OASL, or 2'-5'-oligoadenylate synthetase-like, is a gene that encodes a protein involved in the innate immune response to viral infection. The OASL protein functions by enhancing the production of interferon in response to viral double-stranded RNA and is part of the OAS family, which plays a role in antiviral defense mechanisms.\",",
            "  \"The gene is associated with type I interferon responses\": 9,",
            "  \"The gene is associated with type II interferon responses\": 5,",
            "  \"The gene is associated with type III interferon responses\": 4,",
            "  \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "  \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "  \"The gene has potential value as a blood transcriptional biomarker\": 6,",
            "  \"The gene is a known drug target\": 1,",
            "  \"The gene is therapeutically relevant for diseases involving the immune system\": 7",
            "}",
            "```",
            "",
            "Please note that the scores provided are educated guesses based on current scientific understanding as of my last update, and they are meant to reflect the degree of evidence pertaining to each statement. The actual evidence may vary, and thus these scores should be used as a general guide rather than definitive assessments."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"OASL\",",
            "  \"Brief_summary\": \"The OASL gene encodes an enzyme that is part of the 2'-5'-oligoadenylate synthase family. These enzymes play a crucial role in the innate immune response to viral infection. Upon activation by viral double-stranded RNA, the enzyme becomes active and synthesizes 2'-5'-oligoadenylates (2-5As). These molecules activate RNase L, leading to the degradation of viral RNA. OASL is known to be involved in modulating the type I interferon response and has been implicated in the regulation of antiviral activity.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 9,",
            "    \"The gene is associated with type II interferon responses\": 5,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 8,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 7,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "The scores provided are subjective and based on a general understanding of the gene's functions and current research as of the knowledge cutoff date. They reflect the strength of evidence with regard to each statement, with higher scores indicating stronger evidence. For the most accurate and up-to-date information, further research and data from scientific literature should be consulted."
        ]
    },
    "OTOF": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"OTOF\",",
            "  \"brief_summary\": \"The OTOF gene provides instructions for making a protein called otoferlin, which is essential for normal hearing. Otoferlin is located in the inner ear, where it plays a key role in the process of converting sound waves to electrical signals that can be interpreted by the brain. Mutations in the OTOF gene are associated with a form of nonsyndromic deafness known as DFNB9, which is characterized by profound prelingual sensorineural hearing loss.\",",
            "  \"gene_association_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 0,",
            "    \"The gene is associated with type II interferon responses\": 0,",
            "    \"The gene is associated with type III interferon responses\": 0,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 0,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 2,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 0",
            "  }",
            "}",
            "```",
            "",
            "Note: The scores provided here are hypothetical and are meant to illustrate how the JSON format may look. The actual evidence for the gene OTOF's association with interferon responses, immune system biology, or its status as a biomarker or drug target would need to be determined by a thorough review of the scientific literature. The scores given for \"The gene or its products are currently being used as a biomarker in clinical settings\" and \"The gene has potential value as a blood transcriptional biomarker\" are non-zero to acknowledge that while there may be some research or preliminary findings, they may not be widely accepted or validated."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "    \"gene_name\": \"OTOF\",",
            "    \"Brief_summary\": \"The gene OTOF encodes the protein otoferlin, which is a transmembrane protein known to be essential for the function of cochlear hair cells. Mutations in this gene can lead to a form of deafness known as DFNB9, characterized by prelingual, bilateral, profound sensorineural hearing loss. Otoferlin is involved in the synaptic transmission of auditory signals. It is not primarily known for its role in immune response or in interferon signaling pathways.\"",
            "}",
            "```",
            "",
            "```json",
            "{",
            "    \"The gene is associated with type I interferon responses\": 0,",
            "    \"The gene is associated with type II interferon responses\": 0,",
            "    \"The gene is associated with type III interferon responses\": 0,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 1,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 2,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 1",
            "}",
            "```",
            "",
            "The scores above are based on the current knowledge that OTOF is primarily known for its role in hearing and not in the immune system or interferon responses. There may be some emerging research that touches on these aspects, hence the scores are not absolute zeros for some of the statements, but the evidence is likely to be low or indirect at best. It is important to note that scientific knowledge is ever-evolving, and scores may change as new research emerges."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"OTOF\",",
            "  \"Brief_summary\": \"OTOF encodes otoferlin, a protein that is essential for hearing as it plays a critical role in the exocytosis of synaptic vesicles at the auditory inner hair cell ribbon synapses. Mutations in this gene are associated with auditory neuropathy and deafness, specifically autosomal recessive nonsyndromic deafness. It is not primarily known for functions related to the immune system or interferon responses.\",",
            "  \"Evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 0,",
            "    \"The gene is associated with type II interferon responses\": 0,",
            "    \"The gene is associated with type III interferon responses\": 0,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 1,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 2,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 0",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on current knowledge up to the knowledge cutoff date, and the field of genomics is rapidly evolving. The scores reflect the lack of strong evidence linking the OTOF gene to immune responses or interferon pathways, though there may be minimal research or incidental findings that slightly raise the scores for relevance to immune biology and potential as a biomarker. The low scores indicate that OTOF is not a well-established gene in these areas."
        ]
    },
    "SERPING1": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"SERPING1\",",
            "  \"brief_summary\": \"The SERPING1 gene encodes the C1 inhibitor, a protein that regulates the activity of the complement system, which is part of the body's innate immune system. Mutations in this gene can lead to hereditary angioedema, a disorder characterized by episodic swelling of the skin, airways, and other tissues.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 7,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 9",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided here are not based on specific literature and are illustrative of how someone might rate the evidence for each of these statements. Actual scores should be derived from a thorough review of the scientific literature and the current state of clinical research related to the SERPING1 gene."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"SERPING1\",",
            "  \"brief_summary\": \"SERPING1, also known as C1 inhibitor or C1 esterase inhibitor, is a gene that encodes for a protein primarily involved in the regulation of the complement system and the kallikrein-kinin system. The protein product of SERPING1 is a serine protease inhibitor that plays a crucial role in controlling inflammation and preventing uncontrolled complement activation. Mutations in this gene are associated with hereditary angioedema, which is characterized by episodic swelling of the skin, mucous membranes, and internal organs due to excessive activation of the complement pathway.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 2,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 8,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 9",
            "  }",
            "}",
            "```",
            "The scores assigned to each statement are based on a general understanding of the gene's functions and associations. The evidence for the gene's association with interferon responses is not as strong as its involvement in the complement system, hence the lower scores for interferon-related statements. SERPING1's relevance to circulating leukocytes and immunity, as well as its role in hereditary angioedema, make it therapeutically relevant and a potential biomarker, which is reflected in the higher scores for those statements. The scores are subjective estimates and actual evidence may vary."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"SERPING1\",",
            "  \"brief_summary\": \"The SERPING1 gene encodes the C1 inhibitor, a protein that plays a crucial role in the regulation of the complement system and the intrinsic coagulation (contact activation) pathway. Mutations in this gene can lead to hereditary angioedema, which is characterized by episodic swelling of the skin, gastrointestinal tract, and airways due to unregulated activation of the complement and kallikrein-kinin systems.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 1,",
            "    \"The gene is associated with type II interferon responses\": 1,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 5,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 4,",
            "    \"The gene is a known drug target\": 8,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 9",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are based on a general understanding of the gene's functions and implications in disease states. They do not reflect a comprehensive review of all available literature, and as such, these scores should be taken as a rough estimate rather than a definitive assessment. It is recommended to consult the latest scientific research for more detailed information and evidence regarding the roles of SERPING1 in various biological processes and medical contexts."
        ]
    },
    "TRIM6": {
        "datasvc-openai-compsci-poc-gpt4-turbo_1": [
            "```json",
            "{",
            "  \"gene_name\": \"TRIM6\",",
            "  \"brief_summary\": \"The TRIM6 gene (Tripartite Motif Containing 6) encodes a member of the tripartite motif (TRIM) family. TRIM proteins are involved in various cellular processes including cell proliferation, differentiation, development, oncogenesis, and apoptosis. They are characterized by the presence of a RING finger, one or two B-box domains, and a coiled-coil region. TRIM6 has been implicated in the antiviral response and regulation of innate immune signaling pathways.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 6,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 5",
            "  }",
            "}",
            "```",
            "",
            "Please note that the scores provided are a hypothetical estimation based on the information given in the question. In practice, these scores would need to be derived from extensive literature reviews, experimental evidence, and clinical trial data."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_2": [
            "```json",
            "{",
            "  \"gene_name\": \"TRIM6\",",
            "  \"brief_summary\": \"The TRIM6 gene encodes a member of the tripartite motif (TRIM) family. The protein encoded by this gene contains a RING finger domain, a B-box type 1, a B-box type 2, and a coiled-coil region. The TRIM motif has been identified in proteins that display diverse biological functions, including cell proliferation, oncogenesis, and antiviral activity. Limited evidence suggests that TRIM6 may play a role in antiviral defense mechanisms, particularly in relation to the ubiquitination and degradation of viral proteins, but its exact functions and interactions are not fully characterized.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 4,",
            "    \"The gene is associated with type II interferon responses\": 2,",
            "    \"The gene is associated with type III interferon responses\": 1,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 5,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 1,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 3,",
            "    \"The gene is a known drug target\": 0,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 4",
            "  }",
            "}",
            "```",
            "",
            "Note: The evidence scores provided above are hypothetical and do not represent actual scientific data. They are intended to demonstrate the JSON format for the requested information. Actual evidence scores would require a thorough review of the scientific literature."
        ],
        "datasvc-openai-compsci-poc-gpt4-turbo_3": [
            "```json",
            "{",
            "  \"gene_name\": \"TRIM6\",",
            "  \"brief_summary\": \"TRIM6 (Tripartite Motif Containing 6) is a Protein Coding gene. This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. TRIM6 has been implicated in the regulation of innate immune responses, including antiviral defense mechanisms, although its precise roles and mechanisms of action in immune signaling are still being elucidated.\",",
            "  \"evidence_scores\": {",
            "    \"The gene is associated with type I interferon responses\": 7,",
            "    \"The gene is associated with type II interferon responses\": 4,",
            "    \"The gene is associated with type III interferon responses\": 3,",
            "    \"The gene is relevant to circulating leukocytes immune biology\": 7,",
            "    \"The gene or its products are currently being used as a biomarker in clinical settings\": 2,",
            "    \"The gene has potential value as a blood transcriptional biomarker\": 5,",
            "    \"The gene is a known drug target\": 1,",
            "    \"The gene is therapeutically relevant for diseases involving the immune system\": 6",
            "  }",
            "}",
            "```",
            "",
            "Please note that the evidence scores provided are a hypothetical representation based on a generalized understanding of the gene's functions and potential associations. The scores are not based on specific, current scientific data and should be verified with up-to-date research and clinical findings."
        ]
    }
}